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Acne vulgaris, a chronic condition associated with overgrowth of Propionibacterium acnes 
and Staphylococcus epidermidis, is commonly treated with antibiotics. However, the 
emergence of antibiotic resistance has resulted in a need for alternative therapies. The aim of 
this study is to develop a topical preparation incorporating Essential Oils (EOs) for use 
against acne-associated bacteria and assess its efficacy against prescription therapies Dalacin 
T and Stiemycin. Antimicrobial screening of rosewood, clove bud and litsea EOs against was 
conducted before interactions between binary and ternary combinations were determined 
against P. acnes and S. epidermidis (type and clinical isolates) using Minimum Inhibitory 
Concentrations (MICs) and Fractional Inhibitory Concentrations (FICs).  The EOs were 
characterised by both GC-MS and NMR.  A combination of 0.53 mg/ml litsea, 0.11 mg/ml 
rosewood and 0.11 mg/ml clove bud was formulated into herbal distillates and compared to 
Dalacin T and Stiemycin against antibiotic sensitive and resistant isolates (erythromycin). 
The distillate with EO had synergistic activity against P. acnes (7log10 reduction) and 
indifferent activity against S. epidermidis (6log10 reduction), antimicrobial activity was either 
significantly (p ≤ 0.05) more antimicrobial or equivalent to that of Dalacin T and Stiemycin. 











































































Acne vulgaris, a chronic inflammatory disease of the pilosebaceous unit (Williams et al., 
2012), affects approximately 80% of all 11 to 30 year olds (Bergler-Czop, 2014). The disease 
manifests as seborrhoea, non-inflammatory lesions (comedones), inflammatory lesions 
(papules, pustules, nodules and cysts), and scarring on the face, neck, chest and back 
(Williams et al., 2012), and is associated with substantial physical and psychological 
morbidity (Koo et al., 2014). 
 The pathogenesis of acne vulgaris is not fully understood, however, increased sebum 
production and follicular hyperkeratosis provides an anaerobic, lipid-rich environment in 
which the anaerobic commensal Propionibacterium acnes proliferates and stimulates 
inflammation (Contastot and French, 2014). In addition, Staphylococcus epidermidis, an 
aerobic skin commensal, may be a secondary coloniser that potentiates inflammation (Bek-
Thomsen et al., 2008). 
Topical and oral antibiotics, such as tetracyclines or erythromcyin, are commonly 
prescribed for acne as they inhibit the proliferation of P. acnes and exert anti-inflammatory 
activity (Dawson and Dellavalle, 2013). However, resistance to these antibiotics has been 
observed in P. acnes; resistance to at least one antibiotic was found in 51-94% of isolates in 6 
European countries and was strongly correlated with prescribing patterns (Ross et al., 2003).
 
Antibiotic resistance in S. epidermidis and other coagulase-negative staphylococci also 
increases in prevalence with the duration of therapy (Humphrey, 2012). This provides a 
rationale for seeking alternative antimicrobial treatments for acne vulgaris. 
Essential oils (EOs) are volatile mixtures of plant secondary metabolites obtained by steam 
distillation of plant material (Solorzano-Santos and Miranda-Novales, 2012). Many EOs 
possess broad-spectrum antimicrobial activity, including against antibiotic resistant strains, in 

































































vitro. For example, lemongrass (Cymbopogon flexuosus) EO inhibited methicillin-sensitive 
Staphylococcus aureus and methicillin-resistant S. aureus (MRSA) at 0.06% (Adukwu et al., 
2012). While long term use of synthetic antibiotics is linked to resistance, EOs are complex 
mixtures and are believed to have multiple non-specific mechanisms of action, suggesting 
resistance may be less likely to develop
 
(Alexopoulos et al., 2011).  To date, no significant 
antimicrobial resistance to EOs has been reported
 
(Bakkali et al., 2008). Furthermore, EOs 
often possess other pharmacological activities, such as anti-inflammatory activity, which may 
enhance their therapeutic benefits as acne treatments (Tsai et al., 2011). 
This study aims to identify a synergistic antimicrobial combination of EOs against P. acnes 
and S. epidermidis, and analyse its in vitro efficacy in natural product-based topical 
formulations. The efficacy of the most active topical formulation was then compared to that 
of the topical antibiotic solutions Dalacin T and Stiemycin and their respective active 
ingredients, clindamycin phosphate and erythromycin.  
 
MATERIALS AND METHODS 
Essential Oils. Clove bud (Syzigum aromaticum), litsea (Litsea cubeba) and rosewood 
(Aniba rosaeadora) EOs were obtained from Penny Price Aromatherapy Ltd. (Hinckley, 
UK).  
    Gas Chromatographic Analysis. Major components of EOs were determined using a 
Thermo Focus gas chromatograph (GC) equipped with a flame ionization detector and 
Zebron ZB-5MS column (30m x 0.25 mm, 0.25 µm film thickness). EO samples were diluted 
1:100 in GC-grade hexane (Fisher Scientific, Loughborough, UK) and 0.30 ml volumes 
injected into the GC. Injection temperature was 280ºC and the split ratio 1:34. The column 
temperature was retained at 60ºC for 5 minutes, before increasing to 220ºC at a rate of 
4ºC/min, and to 280ºC at a rate of 11ºC/min. Identification of major components was based 

































































on comparisons to standard reference samples (Sigma Aldrich, Gillingham, UK) where 
possible. GC coupled with mass spectrometry (GC-MS) was performed using a Bruker 450-
GC gas chromatograph coupled with a Bruker 300-MS SQ mass spectrometer (Bruker, 
Billerica, USA) in order to identify remaining major components by NIST library database 
matching. 
1
H NMR Measurements. Proton (
1
H) NMR measurements of EOs were conducted on a 
Bruker Avance 400 MHz spectrometer operating at a frequency of 399.94 MHz and a probe 
temperature of 298 K. A 0.20 ml aliquot of each EO sample was diluted to a final volume of 
0.60 ml with deuterated chloroform (C
2





tetramethylsilane (TMS), the former providing a field frequency lock, the latter as an internal 
chemical shift reference (δ = 0.00 ppm) and quantitative 
1
H NMR standard; these solutions 
were then placed in 5 mm diameter NMR tubes. Typical pulsing conditions were: 128 free 
induction decays (FIDs) using 65,536 data points and a 4.5 s pulse repetition rate, the latter to 
allow full spin-lattice (T1) - relaxation of protons in the samples investigated. Chemical shift 
values of resonances were referenced to TMS (δ = 0.000 ppm, internal) and/or residual 
chloroform (δ = 7.262 ppm). Resonances present in each spectrum were routinely assigned 
by a consideration of chemical shift values, coupling patterns and coupling constants. 
Microorganisms and Culture Methods. Test species were P. acnes (NCTC 737) and S. 
epidermidis (NCTC 7291). Clinical isolates obtained from Leicester Royal Infirmary 
(Leicester, UK) were S. epidermidis PL02202 (erythromycin-sensitive), PL021862 
(erythromycin-resistant) and PL022186 (erythromycin-resistant), and P. acnes PL017109 
(erythromycin-sensitive). All microorganisms were grown in brain heart infusion (BHI) broth 
and cultured on solid media using BHI agar (Sigma Aldrich). P. acnes NCTC 737 was grown 
in a CO2 incubator (Innova CO-170, New Brunswick Scientific, Edison, USA) at 37°C, and 
P. acnes PL017109 in an anaerobic cabinet (MiniMACS Anaerobic Workstation, Don 

































































Whitley Scientific, Shipley, UK). S. epidermidis was grown under aerobic conditions at 
37°C.  
Screening EOs for Antimicrobial Activity. A Kirby-Bauer disc diffusion method was 
used. Agar plates were spread with 0.10 ml test bacterial culture before 2 cm filter paper discs 
spotted with 0.05 ml EO were placed on the agar surface. Plates were incubated for 24 hr. at 
37°C and zone of inhibition (ZOI) measured for each EO tested. 
Determination of Minimum Inhibitory Concentrations (MIC) and Minimum 
Bactericidal Concentrations (MBC) of EOs. Serial two-fold dilutions of EOs (litsea: 0.53-
35.6 mg/ml; rosewood and clove bud: 0.66-44 mg/ml) were prepared in BHI broth with 10% 
(v/v) dimethyl sulfoxide (Fisher Scientific) to a final volume of 9.90 ml. A 0.10 ml aliquot of 
either P. acnes (10
6
 colony forming units (CFU)/ml
-1







added before incubation at 37°C for 24 hr.
 
Controls were BHI broth with 10% (v/v) dimethyl 
sulfoxide and 0.10 ml organism only. MICs were determined as the lowest concentration of 
EO where no bacterial growth was observed. MBCs were determined by sub-culturing 0.10 
ml aliquots of the test solutions after incubation onto BHI agar plates, which were then 
incubated for 24 hr. and any growth observed. 
Assessment of Synergistic Antimicrobial Interactions. The checkerboard method
 
(Mulyaningsih et al., 2010) was used to investigate potential synergistic, indifferent or 
antagonistic relationships between binary and ternary combinations of EOs by determination 
of Fractional Inhibitory Concentrations (FIC) and FICIs. Serial two-fold dilutions of EOs to 
yield final concentrations between the MIC and 0.89 mg/ml for litsea and 0.11 mg/ml for 
rosewood and clove bud EOs were prepared in BHI broth with 10% (v/v) dimethyl sulfoxide 
and inoculated with either P. acnes or S. epidermidis. Binary and ternary combinations of 
these variable concentrations were added to 96-well plates. The optical densities (595 nm) of 
the samples were obtained using a Spectramax Plus 384 microplate reader and Softmax Pro 

































































version 6.4 software (Molecular Devices, Sunnyvale, USA) at 0 hr., and again after 24 hr. 
incubation at 37°C.  
MICs and FICIs of the combinations of the EOs were then calculated: 







Synergistic, indifferent or antagonistic interactions were concluded from the following 
limits: Synergy: FICI ≤ 0.5, indifferent: 0.5 > FICI < 4, antagonism: FICI > 4 (Odds, 2003). 
FIC data for each EO in the ternary combination was then employed to generate 3D 
isobolograms
 
(Yoon et al., 2004) using Minitab version 17.2.1 (Minitab Inc., State College, 
USA). 
Efficacy of EO Blend within Topical Formulations. A ternary combination of 0.53 
mg/ml litsea, 0.11 mg/ml clove bud and 0.11 mg/ml rosewood EOs found to inhibit both P. 
acnes and S. epidermidis was tested for antimicrobial activity in two topical cosmetic toner 
preparations comprising of either neroli (Citrus aurantium var amara) or Roman chamomile 
(Chamaemelum nobile) herbal distillate (hydrolat) with 0.5% (v/v) ethanol (Fisher Scientific) 
added as an EO solvent. A method adapted from the British Standard preservative efficacy 
test
 
(British Standards Institute, 2012) was used. Formulations were prepared and inoculated 








) before being incubated 
for 24 hr. at either 25°C (skin surface temperature) or 37°C (pilosebaceous unit temperature), 
spread plated onto BHI agar and enumerated. This was repeated with the most efficacious 
topical preparation against P. acnes and S. epidermidis clinical isolates. Controls were 
hydrolat alone and hydrolat with 0.5% (v/v) ethanol. 
Comparison of Efficacy of Neroli Toner to Current Prescription Therapies. The 
antimicrobial efficacy of the neroli toner was compared to the prescription only topical 
antibiotic preparations Dalacin T and Stiemycin by determining log10 CFU/ml reductions of 
S. epidermidis and P. acnes type strains together with clinical isolates S. epidermidis 

































































PL021862, PL022186 and PL02202 and P. acnes PL017109 after 24 hr. incubation at 25°C 
and 37°C according to the adapted British Standard preservative efficacy test method. In 
addition, the ternary combination of 0.53 mg/ml litsea, 0.11 mg/ml clove bud and 0.11 mg/ml 
rosewood EOs was compared to that of the Dalacin T and Stiemycin active ingredients, 10 
mg/ml clindamycin phosphate and 20 mg/ml erythromycin (Sigma Aldrich), respectively. 
Active ingredients were suspended in BHI broth and 0.5% (v/v) ethanol was used as a solvent 
for the EO combination. Controls were BHI broth with 0.5% (v/v) ethanol, and BHI broth 
alone.  
All investigations were carried out in triplicate on at least two separate occasions. 
Statistical Analysis. Two-way analysis of variance with Tukey’s comparisons was 
conducted using Minitab Statistical Software version 16 (Minitab Inc., State College, USA) 
in order to determine the significance of any differences (p ≤ 0.05) in mean log10 reductions 
between topical preparations and their controls.  
 
RESULTS AND DISCUSSION 
Antimicrobial Activity of EOs. Initial screening showed that clove bud, litsea and 
rosewood had mean ZOIs of 3.9 mm ± 0.03, 9.0 mm ± 0.00 and 9.0 mm ± 0.00 for P. acnes, 
and 2.8 mm ± 0.03, 1.7 mm ± 0.06 and 3.2 mm ± 0.03 against S. epidermidis.  
MICs of clove bud and rosewood EOs were 1.38 mg/ml against both S. epidermidis and P. 
acnes. Litsea had an MIC of 1.11 mg/ml against S. epidermidis; however, it exerted less 
antimicrobial activity against P. acnes (MIC = 2.23 mg/ml). EOs were bactericidal against S. 
epidermidis, with MBCs of 2.23 mg/ml for litsea, and 2.75 mg/ml for rosewood and clove 
bud EOs, however, only the clove bud EO was bactericidal against P. acnes (MBC = 5.5 
mg/ml). Previous investigations have reported MICs of 0.25% (v/v) for clove bud EO against 

































































S. epidermidis (Fu et al., 2007) in accordance with the current findings. However, the MIC of 
clove bud EO against P. acnes was greater than the previously reported MIC of 0.31 mg/ml
 
Fu et al., 2009) which may be the result of variation in isolate susceptibility or EO 
composition between studies (Verma et al., 2015). Antimicrobial activity of litsea and 
rosewood EOs has been reported against species such as S. aureus (MICs = 0.2 and 0.5 
mg/ml, respectively; Wang and Liu, 2010; Rosato et al., 2010) 
Assessment of Synergistic Antimicrobial Interactions Between EOs. Synergistic 
interactions were observed between all binary combinations of litsea, clove bud and 
rosewood EOs against S. epidermidis. MICs of these EOs in combination were 0.11 mg/ml 
rosewood with 0.33 mg/ml clove bud (FICI = 0.32), and 0.09 mg/ml litsea with 0.11 mg/ml 
rosewood (FICI = 0.16) or 0.33 mg/ml clove bud EO (FICI = 0.32). A combination of litsea 
(0.53 mg/ml) and rosewood EOs (0.33 mg/ml) was synergistic against P. acnes (FICI = 0.48), 
however, combinations containing clove bud EO were indifferent (FICIs = 0.58 - 1.08). 
Synergistic binary combinations of bergamot (C. bergamia) and basil (Ocimum basilicum) 
EOs reportedly engendered a greater leakage of cellular contents of B. subtilis, E. coli and S. 
aureus compared to EOs alone, suggesting enhanced cell membrane disintegration (Lv et al., 
2011). Furthermore, disintegration of the membrane by one component may increase the 
cellular uptake of other antimicrobial components (Santiesteban-Lopez et al., 2007). 
A combination of 0.53 mg/ml litsea, 0.11 mg/ml rosewood and 0.11 mg/ml clove bud EOs 
was synergistic against P. acnes (FICI = 0.40), whilst a combination of 0.09 mg/ml litsea, 
0.11 mg/ml clove bud and 0.11 – 0.33 mg/ml rosewood EOs was synergistic against S. 
epidermidis (FICI = 0.24), as illustrated by concave areas of 3D isobolograms (Figures 1a 
and 1b). The lowest combination of EOs required to inhibit both test species was 0.53 mg/ml 
litsea, 0.11 mg/ml rosewood and 0.11 mg/ml clove bud EOs. As such, the quantity of EOs 

































































required to inhibit these microorganisms was further reduced, which may decrease the 
likelihood of adverse effects with topical application (Casetti et al., 2012).  
Chemical Composition of EOs. GC analysis indicated that citral was the most abundant 
compound present in litsea EO (49.64%), while eugenol was most abundant in clove bud EO 
(60.90%), and linalool represented the predominant agent present in rosewood EO (86.73%), 
in accordance with previous research (Fu et al., 2007; Rosato et al., 2010; Wang and Liu, 
2010). 
1
H NMR spectroscopy data acquired is in agreement with that from GC analysis 
(Figure 2).  
 Antimicrobial Efficacy of the Ternary EO Combination in Cosmetic Toner Topical 
Formulations. The ternary combination of EOs was tested for antimicrobial activity in two 
toner formulations based on neroli or Roman chamomile hydrolats. Hydrolats are water-
based by-products of steam distillation of plant material, and contain some water-soluble 
components of EOs (Lin et al., 2011). Both hydrolats were antimicrobial, resulting in 
reductions of between 0.67 and 4.76 log10 (Table 1). Few studies have investigated the 
antimicrobial activity of hydrolats; however, Chinese olive (Canarium album) hydrolat was 
reportedly antimicrobial against P. acnes and S. epidermidis (ZOIs = 15.2 mm and 21.0 mm, 
respectively; Lin et al., 2011). Temperature did not significantly (p ≥ 0.05) affect the activity 
of Roman chamomile hydrolat, however, activity of neroli hydrolat was significantly (p ≤ 
0.05) increased at 37°C.  
Ethanol (0.5% v/v) was added to the hydrolat as an EO solvent. This concentration of 
ethanol was not antimicrobial (data not shown), however significantly (p ≤ 0.05) increased 
the activity of neroli hydrolat  against S. epidermidis and P. acnes, resulting in complete 
inhibition of P. acnes at 37°C and S. epidermidis at both temperatures. Furthermore, Roman 
chamomile hydrolat was significantly (p ≤ 0.05) more antimicrobial against S. epidermidis 

































































with the addition of ethanol, with 5.5 and 5.2 log10 reductions being observed at 25°C and 
37°C, respectively. Although antimicrobial interactions between ethanol and hydrolats have 
not previously been studied, a non-lethal concentration of ethanol was synergistic with the 
lipid sapienic acid against MRSA. Ethanol is a penetration enhancer, and in this manner may 
increase partitioning of antimicrobial components into the cell membrane or enhance entry 
into the cytoplasm (Drake et al., 2008). 
The complete toner formulations (hydrolat, ethanol and EOs) completely destroyed P. 
acnes at 25°C. This was significantly (p ≤ 0.05) greater than reductions achieved by hydrolat 
with ethanol, suggesting that EOs significantly contribute to the antimicrobial activity of the 
formulation. S. epidermidis was also completely destroyed by neroli and Roman chamomile 
toners; this activity was equivalent (p ≥ 0.05) to that of a combination of hydrolat with 
ethanol, indicating that the EOs do not provide any additional benefit to the topical 
formulation for the control of S. epidermidis.  
Additionally, the neroli toner with EOs completely inhibited all three clinical isolates of S. 
epidermidis, and one of P. acnes, including the antibiotic resistant strains S. epidermidis 
PL021862 and PL022186. Considering the variation in antimicrobial susceptibility of isolates 
from individual acne patients, and between patients (Humphrey, 2012) this data demonstrates 
the potential use of this formulation as a novel product for the control of P. acnes and S. 
epidermidis. 
Comparison of Neroli Toner Efficacy to that of Dalacin T and Stiemycin. The topical 
antibiotic solutions Dalacin T and Stiemycin resulted in complete inhibition of all test 
species. The neroli toner formulation possesses an equivalent antimicrobial activity (Table 1), 
further supporting its use for the control of acne vulgaris. 

































































Comparison of the Neroli Toner, Dalacin T and Stiemycin Active Ingredients. Overall, 
there was a high level of variability in antimicrobial activity between the active ingredients, 
which was dependent on strain/isolate and incubation temperature (Table 2). Erythromycin 
produced significantly (p ≤ 0.05) greater reductions than clindamycin phosphate and EOs 
against S. epidermidis PL021862 at 37°C, and S. epidermidis PL02202 and P. acnes type 
strain, at both temperatures (Table 2). Interestingly, erythromycin completely inhibited the 
erythromycin-resistant S. epidermidis isolate PL021862 at 37°C. However, the concentration 
of 20 mg/ml found in Stiemycin is significantly greater than the MIC breakpoint for 
resistance to erythromycin of 2 mg/ml in staphylococci (BSAC, 2015). EOs were 
significantly (p ≤ 0.05) less antimicrobial than clindamycin phosphate against S. epidermidis 
PL021862 and P. acnes at 37°C. However, EOs were not significantly (p ≥ 0.05) different in 
activity to clindamycin phosphate against S. epidermidis isolate PL021862 at 25°C, and 
PL022186 and PL02202 at both temperatures.  Furthermore, EOs were significantly (p ≤ 
0.05) more antimicrobial than clindamycin phosphate against P. acnes at 25°C, and both 
antibiotics against the P. acnes clinical isolate PL017109 and S. epidermidis type strain, 
indicating that the EOs could be useful as novel antibiotic alternatives. 
Log10 CFU/ml reductions achieved by all three active ingredients were significantly (p ≤ 
0.05) lower than the complete inhibition achieved by their complete formulations. Dalacin T 
contains 50% (v/v) isopropyl alcohol, and Stiemycin contains absolute ethanol (unspecified 
quantity), which are both bactericidal agents and may increase the antimicrobial activity of 
the complete formulations over that of their active ingredients. The combination of neroli 
hydrolat and ethanol were demonstrated to be significantly antimicrobial and hence increase 
the antimicrobial activity of the toner when incorporated (Table 1).  This indicates that the 
complete formulation is essential to the inhibition of bacteria contributing to acne vulgaris. 

































































Novel antibiotic alternatives for the control of acne vulgaris-associated bacteria are required 
to combat antibiotic resistance. In this study, a neroli toner formulation was equivalent in 
activity to two current topical antibiotic solutions, including against erythromycin-resistant 
clinical isolates of S. epidermidis. The active ingredients of the neroli toner, a ternary 
combination of litsea, clove bud and rosewood EOs, had equivalent or even greater 
antimicrobial activity than that of clindamycin phosphate, erythromycin, or both against all 
but the P. acnes type strain at 37°C, and one clinical isolate of S. epidermidis. Therefore, the 
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Table 1. Log10 reductions of P. acnes and S. epidermidis in cosmetic toner formulations after 
24 hr. incubation at 25°C and 37°C (n=6, mean ± SEM).  
Formulation 































































































































































Table 2. Log10 reductions of P. acnes and S. epidermidis by active ingredients of the neroli 
toner, Dalacin T and Stiemycin at 25°C and 37°C (n=6, mean ± SEM).  
Organism 
EOs Clindamycin Phosphate Erythromycin 
25°C 37°C 25°C 37°C 25°C 37°C 
P. acnes 1.95 ± 0.09 -0.62 ± 0.15 0.36 ± 0.02 1.81 ± 0.01 7.19± 0.00
 a
 6.39 ± 0.46 
P. acnes 
PL017109 
4.15 ± 0.11 6.41 ± 0.16 0.17 ± 0.02 0.17 ± 0.03 2.50 ± 0.21 2.87 ± 0.01 












1.56 ± 0.14 1.04 ± 0.21 -0.49 ± 0.73 -1.76 ± 0.00 -0.01 ± 0.14 0.50 ± 0.05 
S. epidermidis 
PL02202  







































































Figure 1: 3D plot of fractional inhibitory concentrations of litsea, rosewood and clove bud EOs against a) P. 
acnes and b) S. epidermidis.  
(Figures 1a and 1b).  
153x245mm (96 x 96 DPI)  
 
 



































































Figure 2: 400 MHz 1H NMR spectra of a) clove, b) litsea and c) rosewood EOs 
respectively.   %"Assignments:   a) 1, βC-C14-CH3; 2, βC-C15-CH3; 3, Ethanol-CH3; 4, βC-C2-CH2a; 5, βC-
C13-CH3; 6, βC-C2-CH2b/C10-CH2; 7,βC-C3-CH2a; 8, βC-C6-CH2a; 9, βC-C3-CH2b; 10, βC-C7CH2a; 11, AcEug-
CO-CH3; 12, βC-C7-CH2b/C6-CH2; 13, βC-C9-CH; 14, Eug-Ar-CH2; 15, AcEug-Ar-CH2; 16, Ethanol-CH2OH; 
17, AcEug-O-CH3; 18, Eug-O-CH3; 19, βCC12-CH2a; 20, βC-C12-CH2b; 21, Eug/Ac-Eug-CH2=CH; 22, βC-C5-
CH; 23, Eug/AcEug-CH2=CH; 24, Eug-Ar1; 25, AcEug-Ar1; 26, Eug-Ar2; 27, AcEug-Ar2.  %"b) 1, Euc-C11-
CH3; 2, Euc-C9/10-CH3’s; 3, Euc-C3-CH; 4, G-C8-CH3 / N-C8-CH3; 5,L-C7-CH3; 6, G-C8’-CH3 / N-C8’-CH3; 7, 
L-C10-CH3; 8, N-C3’-CH3; 9, G-C3’-CH3; 10, N-C4/5-CH2’s / G-C5-CH2; 11, G-C4-CH2; 12, L-C7-CH2; 13, N-
C6-CH / G-C6CH ; 14, L-C2-CH; 15, N-C2-CH / G-C2-CH ; 16, N-C1-CHO; 17, 16, G-C1-CHO.  %"c) 1, Lin-
C3-CH3; 2, Lin-C4-CH2; 3, Lin-C7-CH3; 4, Lin-C8-CH3; 5,Lin-C5-CH2; 6, LinC1-CH2a; 7, Lin-C6-CH; 8, Lin-C1-
CH2b; 9, Lin-C2-CH.   Abbreviations: βC, β-Caryophyllene; Eug, Eugenol; AcEug, Eugenyl acetate; Ar, 
Aromatic-H; Euc, Eucalyptol; G, Geranial; N, Neral; L, Limonene; Lin, Linalool %"    
(Figure 2).  
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